NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/01/2022
Back to search
Official data from USPTO
-ELOSTERA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
10/01/2022
Trademark type
Combined
Nice classes
1, 5, 31
Filing date
09/08/2020
Registration date
09/21/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/21/2021
Last transaction
09/21/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
NO
Examiner
WHITE, TRAVIS WILLIAM
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a lowercase Greek letter alpha followed by "-ELOSTERA".
Holders and representatives
Holders
S. A. (pessoa física)
Representatives
Miriam D. Trudell Sheridan Ross P.C.
Technical classification
Nice Classes
Class 1Class 5Class 31
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry and science; chemicals for use in biotechnological manufacturing processes; antioxidants for use in the manufacture of pharmaceuticals
Class 5
Pharmaceutical preparations for preventing spread of cancer cells; pharmaceutical preparations for mitigating negative side effects of chemo- and radiotherapy related to cancer; pharmaceutical preparations for controlling diabetes; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for treating malignant tumors; veterinary preparationspreparations for preventing spread of cancer cells and mitigating negative side effects of chemo- and radiotherapy related to cancer; medical preparations for the reduction of side effects of chemotherapy and radiation therapy; pharmaceutical preparations for treating diabetes; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical drugs for the treatment of cancer; pharmaceutical preparations for human use for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical compositions for the treatment and prevention of cancer; empty capsules for pharmaceuticals; nutritional supplements for veterinary use; dietary supplements for human beings and animals
Class 31
Raw and unprocessed agriculturalaquaculturalhorticultural and forestry productsplant seedssowing seedscrop seedsunprocessed oil seedsseeds for fruit and vegetablesseeds for plantingseeds for agricultural purposesbitter melon seedsgenetically modified forms of all the aforementioned seeds
Publications
History of USPTO decisions and trademark events.
22 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/10/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/22/2022
FIMP
FINAL DISPOSITION PROCESSED
03/22/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/21/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
09/21/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/06/2021
PUBO
PUBLISHED FOR OPPOSITION
07/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/16/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/26/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/26/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/26/2021
RFNT
REFUSAL PROCESSED BY IB
03/01/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/09/2021
RFRR
REFUSAL PROCESSED BY MPU
02/09/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/28/2021
CNRT
NON-FINAL ACTION WRITTEN
01/27/2021
DOCK
ASSIGNED TO EXAMINER
01/15/2021
MAFR
APPLICATION FILING RECEIPT MAILED
01/02/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/29/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/24/2020
Continuous trademark protection
Get notified about every new filing that threatens -ELOSTERA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.